Departments : Clinical : Clinical Trial Studies
Hereditary Angioedema Inadequately Controlled(HAE)
Title: Study for adults with Hereditary Angioedema
Summary: Winthrop University Hospital Clinical Trials Center is seeking volunteers with inadequately controlled Hereditary Angioedema (HAE).
Description: This clinical research study is to test a medication already approved by the Food and Drug Administration (FDA) but, to investigate the safety and effectiveness of a higher dosage not approved by the FDA.
Eligible participants will receive study-related medication and medical care at no cost to them. Compensation travel expenses may also be available. Main inclusion criteria: ¥ Diagnosis of HAE with a documented history of swelling ¥ Have a history of an average of more than one HAE attack each month of any severity. ¥ Must be receiving the recommended CINRYZEª (c1 Esterase Inhibitor [Human]) dosing of 1000 U every three to four days via intravenous injection
Principal Investigator: Mark Davis-Lorton, MD
Department: Clinical Trials Center
For More information please call: